Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review
Rami Burstein, Andrew Blumenfeld, Stephen D. Silberstein, et al.
Headache The Journal of Head and Face Pain (2020) Vol. 60, Iss. 7, pp. 1259-1272
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

Botulinum Toxin: An Update on Pharmacology and Newer Products in Development
Supriyo Choudhury, Mark R. Baker, Suparna Chatterjee, et al.
Toxins (2021) Vol. 13, Iss. 1, pp. 58-58
Open Access | Times Cited: 121
Trigeminal neuralgia
Sait Ashina, Carrie E. Robertson, Anan Srikiatkhachorn, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 20
CGRP-targeted medication in chronic migraine - systematic review
Renato Oliveira, Raquel Gil‐Gouveia, Francesca Puledda
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 16
Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review
Andrew Blumenfeld, Benjamin Frishberg, Jack Schim, et al.
Pain and Therapy (2021) Vol. 10, Iss. 2, pp. 809-826
Open Access | Times Cited: 78
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
Luigi Francesco Iannone, Davide Fattori, Silvia Benemei, et al.
CNS Drugs (2022) Vol. 36, Iss. 2, pp. 191-202
Open Access | Times Cited: 62
Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
Laszlo Mechtler, Nicolas Saikali, Jennifer McVige, et al.
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 42
Migraine attacks are of peripheral origin: the debate goes on
Thien Phu, Anders Hougaard, Gregory Dussor, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 28
Botox (onabotulinumtoxinA) mechanism of action
Mitchell F. Brin, Rami Burstein
Medicine (2023) Vol. 102, Iss. S1, pp. e32372-e32372
Open Access | Times Cited: 28
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention
Lanfranco Pellesi, Messoud Ashina, Paolo Martelletti
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 1, pp. 57-64
Open Access | Times Cited: 10
Botulinum Toxin in the Treatment of Headache
Werner J. Becker
Toxins (2020) Vol. 12, Iss. 12, pp. 803-803
Open Access | Times Cited: 61
Association between response to triptans and response to erenumab: real-life data
Ilaria Frattale, Valeria Caponnetto, Alfonsina Casalena, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 50
Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review
Negar Shaterian, Negin Shaterian, Aref Ghanaatpisheh, et al.
Pain Research and Management (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 31
Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis
Joseph Jankovic, Jean Carruthers, Markus Naumann, et al.
Toxins (2023) Vol. 15, Iss. 5, pp. 342-342
Open Access | Times Cited: 17
Update on Non-Interchangeability of Botulinum Neurotoxin Products
Mitchell F. Brin, Mariana Nelson, Nazanin Ashourian, et al.
Toxins (2024) Vol. 16, Iss. 6, pp. 266-266
Open Access | Times Cited: 7
ThermoTRP channels in pain sexual dimorphism: new insights for drug intervention
David Cabañero, Eva Villalba‐Riquelme, Gregorio Fernández‐Ballester, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108297-108297
Open Access | Times Cited: 25
Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches
Katarzyna Kępczyńska, Izabela Domitrz
Toxins (2022) Vol. 14, Iss. 9, pp. 619-619
Open Access | Times Cited: 23
Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review
Antonio Russo, Luigi Francesco Iannone, Ilaria Orologio, et al.
Toxins (2025) Vol. 17, Iss. 4, pp. 192-192
Open Access
Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia
Kazuya Yoshida
Toxins (2021) Vol. 13, Iss. 9, pp. 605-605
Open Access | Times Cited: 28
Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review
Ann Murray, Jennifer I. Stern, Carrie E. Robertson, et al.
Current Pain and Headache Reports (2022) Vol. 26, Iss. 10, pp. 783-794
Closed Access | Times Cited: 21
OnabotulinumtoxinA: Still the Present for Chronic Migraine
Carlo Baraldi, Flavia Lo Castro, Raffaele Ornello, et al.
Toxins (2023) Vol. 15, Iss. 1, pp. 59-59
Open Access | Times Cited: 11
Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine
Cinder Faith Cohen, Jueun Roh, Sang Hoon Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7897-7897
Open Access | Times Cited: 11
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
Andrew Blumenfeld, Richard B. Lipton, Stephen D. Silberstein, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 5, pp. 1533-1551
Open Access | Times Cited: 11
Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain
Ana Bagüés, Jiaxin Hu, Ishraq Alshanqiti, et al.
Pharmacology & Therapeutics (2024) Vol. 259, pp. 108668-108668
Closed Access | Times Cited: 4
Early effect of onabotulinumtoxinA on EEG‐based functional connectivity in patients with chronic migraine: A pilot study
Matteo Conti, Roberta Bovenzi, Maria Giuseppina Palmieri, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 7, pp. 825-837
Open Access | Times Cited: 4
Current and Novel Therapies for Cluster Headache: A Narrative Review
B. Dias, Christopher L. Robinson, María Dolores Villar‐Martínez, et al.
Pain and Therapy (2024)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top